Literature DB >> 30977944

Atypical Lone Pair-π Interaction with Quinone Methides in a Series of Imido-Ferrociphenol Anticancer Drug Candidates.

Yong Wang1,2, Pascal Pigeon1,2, Siden Top2, Juan Sanz García1, Claire Troufflard2, Ilaria Ciofini1, Michael J McGlinchey3, Gérard Jaouen1,2.   

Abstract

Ferrociphenols, especially those possessing a heterocycle at the terminus of an aliphatic chain, display strong anticancer activity through a novel redox mechanism that generates active metabolites such as quinone methides (QMs). X-ray crystallography and UV/Vis spectroscopy reveal that the specific lone pair (lp)-π interaction between a carbonyl group of the imide and the quinone motif of the QM plays an important role in the exceptional cytotoxic behaviour of their imido-ferrociphenol precursors. This intramolecular lp-π interaction markedly enhanced the stability of the QMs and lowered the pKa values of the corresponding phenol/phenolate couples. As the first example of such a non-covalent interaction that stabilizes QMs remotely, it not only expands the scope of the lp-π interaction in supramolecular chemistry, but also represents a new mode of stabilization of a QM. This unprecedented application of lp-π interactions in imido-ferrociphenol anticancer drug candidates may also have great potential in drug discovery and organocatalyst design.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; bioinorganic chemistry; ferrocifen; non-covalent interactions; quinones

Year:  2019        PMID: 30977944     DOI: 10.1002/anie.201902456

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  6 in total

1.  4-Amino-1,8-naphthalimide-ferrocene conjugates as potential multi-targeted anticancer and fluorescent cellular imaging agents.

Authors:  Alex D Johnson; Joseph A Buhagiar; David C Magri
Journal:  RSC Med Chem       Date:  2021-10-21

2.  Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers.

Authors:  Hong-Gui Xu; Viktor Reshetnikov; Marit Wondrak; Lisa Eckhardt; Leoni A Kunz-Schughart; Christina Janko; Rainer Tietze; Christoph Alexiou; Hannes Borchardt; Achim Aigner; Wenjie Gong; Michael Schmitt; Leopold Sellner; Steffen Daum; Hülya Gizem Özkan; Andriy Mokhir
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

3.  Succinimido-Ferrocidiphenol Complexed with Cyclodextrins Inhibits Glioblastoma Tumor Growth In Vitro and In Vivo without Noticeable Adverse Toxicity.

Authors:  Feten Najlaoui; Benoit Busser; Germain Sotoing Taïwe; Pascal Pigeon; Nathalie Sturm; Diane Giovannini; Naziha Marrakchi; Ali Rhouma; Gérard Jaouen; Stéphane Gibaud; Michel De Waard
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

4.  α-Hydroxylactams as Efficient Entries to Diversely Functionalized Ferrociphenols: Synthesis and Antiproliferative Activity Studies.

Authors:  Pascal Pigeon; Marie Gaschard; Mohamed Othman; Michèle Salmain; Gérard Jaouen
Journal:  Molecules       Date:  2022-07-16       Impact factor: 4.927

Review 5.  Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.

Authors:  Pierre Idlas; Elise Lepeltier; Gérard Jaouen; Catherine Passirani
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

6.  N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells.

Authors:  Viktor Reshetnikov; Hülya Gizem Özkan; Steffen Daum; Christina Janko; Christoph Alexiou; Caroline Sauer; Markus R Heinrich; Andriy Mokhir
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.